| Literature DB >> 28011194 |
Ashok-Kumar Dilly1, Keqin Tang2, Yande Guo3, Sangeeta Joshi4, Prasanna Ekambaram5, Krishna Rao Maddipati6, Yinlong Cai7, Stephanie C Tucker8, Kenneth V Honn9.
Abstract
12-Lipoxygenase (12-LOX) metabolizes arachidonic acid to 12(S)-hydroxyeicosatetraenoic acid, or 12(S)-HETE, a proinflammatory bioactive lipid implicated in tumor angiogenesis, growth, and metastasis. The mechanisms underlying 12-LOX-mediated signaling in cancer progression are still ill-defined. In the present study we demonstrate that 12-LOX phosphorylation and subsequent enzymatic activity occurs after integrin β4 stimulation and Src kinase recruitment to the integrin subunit. Inhibition of Src activity by PP2 or Src dominant-negative mutants reduced 12-LOX tyrosine phosphorylation and 12(S)-HETE production in response to integrin β4 stimulation in A431 cells. The pertinent Src-targeted residues for 12-LOX activity were mapped to Y19 and Y614, where 12-LOX mutants Y19F and Y614F showed 70% less enzymatic activity. Furthermore, we have shown that the 12-LOX activity modulated by these residues impacts migration. To our knowledge, this is the first report that c-Src kinase activity is required for β4-integrin-mediated phosphorylation of 12-LOX. Published by Elsevier Inc.Entities:
Keywords: 12-Lipoxygenase phosphorylation; C-Src kinase; Cell migration; β4 Integrin
Mesh:
Substances:
Year: 2016 PMID: 28011194 PMCID: PMC5303182 DOI: 10.1016/j.yexcr.2016.12.011
Source DB: PubMed Journal: Exp Cell Res ISSN: 0014-4827 Impact factor: 3.905